Mechanism of salt-sensitive hypertension: Focus on adrenal and sympathetic nervous systems

Journal of the American Society of Nephrology

Volumn 25, Issue 6, 2014, Pages 1148-1155

  Fujita, Toshiro ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE RECEPTOR; EPITHELIAL SODIUM CHANNEL; GLUCOCORTICOID RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MINERALOCORTICOID RECEPTOR; RAC1 PROTEIN; SPIRONOLACTONE;

ADRENAL GLAND; ADRENERGIC SYSTEM; CARDIORENAL SYNDROME; DEOXYCORTICOSTERONE-SALT INDUCED HYPERTENSION; HUMAN; HYPERTENSION; KIDNEY DISTAL TUBULE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RESISTANT HYPERTENSION; REVIEW; SALT LOADING; SALT SENSITIVE HYPERTENSION; SODIUM ABSORPTION; ANIMAL; BLOOD PRESSURE; INNERVATION; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RENOVASCULAR HYPERTENSION; SALT INTAKE;

ANIMALS; BLOOD PRESSURE; HUMANS; HYPERTENSION, RENAL; KIDNEY; SODIUM CHLORIDE, DIETARY; SYMPATHETIC NERVOUS SYSTEM;

EID: 84906092409     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013121258     Document Type: Review

References (87)

1. Luft FC, Weinberger MH: Heterogenous responses to changes in dietary salt intake: The salt-sensitivity paradigm.Am J Clin Nutr 65[2 Suppl]: 612S-617S, 1997
2. Fujita T, Henry WL, Bartter FC, Lake CR, Delea CS: Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med 69: 334-344, 1980
3. Guyton AC: The surprising kidney-fluid mechanism for pressure control-its infinite gain! Hypertension 16: 725-730, 1990
4. Hall JE, Mizelle HL, Hildebrandt DA, Brands MW: Abnormal pressure natriuresis. A cause or a consequence of hypertension? Hypertension 15: 547-559, 1990
5. Fujita T, Ando K: Hemodynamic and endocrine changes associated with potassium supplementation in sodium-loaded hypertensives. Hypertension 6: 184-192, 1984
6. JiW, Foo JN,O'Roak BJ, Zhao H, LarsonMG, Simon DB, Newton-Cheh C, State MW, Levy D, Lifton RP: Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 40: 592-599, 2008
7. Coffman TM: Under pressure: The search for the essential mechanisms of hypertension. Nat Med 17: 1402-1409, 2011
8. Gonzalez-Villalobos RA, Billet S, KimC, Satou R, Fuchs S, Bernstein KE, Navar LG: Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusion. J Am Soc Nephrol 22: 449-459, 2011
9. Gonzalez-Villalobos RA, Janjoulia T, Fletcher NK, Giani JF, Nguyen MT, Riquier-Brison AD, Seth DM, Fuchs S, Eladari D, Picard N, Bachmann S, Delpire E, Peti-Peterdi J, Navar LG, Bernstein KE, McDonough AA: The absence of intrarenal ACE protects against hypertension. J Clin Invest 123: 2011-2023, 2013
10. Kobori H, Nishiyama A, Abe Y, Navar LG: Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 41: 592-597, 2003
11. Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, Spurney RF, Kim HS, Smithies O, Le TH, Coffman TM: Distinct roles for the kidney and systemic tissues in blood pressure regulation by the reninangiotensin system. J Clin Invest 115: 1092-1099, 2005
12. Gurley SB, Riquier-Brison AD, Schnermann J, Sparks MA, Allen AM, Haase VH, Snouwaert JN, Le TH, McDonough AA, Koller BH, Coffman TM: AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab 13: 469-475, 2011
13. Strazzullo P,Galletti F, BarbaG: Altered renal handling of sodium in human hypertension: Short review of the evidence. Hypertension 41: 1000-1005, 2003
14. Chiolero A, Maillard M, Nussberger J, Brunner HR, Burnier M: Proximal sodium reabsorption: An independent determinant of blood pressure response to salt. Hypertension 36: 631-637, 2000
15. Keszei AP, Tislér A, Backx PH, Andrulis IL, Bull SB, Logan AG: Molecular variants of the thiazide-sensitive Na+-Cl-cotransporter in hypertensive families. JHypertens 25: 2074-2081, 2007
16. Shibata S, Mu S, Kawarazaki H, Muraoka K, Ishizawa K, Yoshida S, Kawarazaki W, TakeuchiM, Ayuzawa N,Miyoshi J, Takai Y, Ishikawa A, Shimosawa T, Ando K, Nagase M, Fujita T: Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J Clin Invest 121: 3233-3243, 2011
17. Mu SY, Shimosawa T, Ogura S, Wang H, Uetake Y, Kawakami-Mori F, Marumo T, Yatomi Y, Geller DS, Tanaka H, Fujita T: Epigenetic modulation of the renal b-adrenergic-WNK4 pathway in salt-sensitive hypertension. Nat Med 17: 573-580, 2011
18. Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T: Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress. Hypertension 50: 877-883, 2007
19. Matsui H, Ando K, Kawarazaki H, Nagae A, Fujita M, Shimosawa T, Nagase M, Fujita T: Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder. Hypertension 52: 287-294, 2008
20. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA, Bornstein SR: Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A 100: 14211-14216, 2003
21. Nagase M, Yoshida S, Shibata S, Nagase T, Gotoda T, Ando K, Fujita T: Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: Possible contribution of fat-derived factors. J Am Soc Nephrol 17: 3438-3446, 2006
22. Fujita T: Mineralocorticoid receptors, saltsensitive hypertension, and metabolic syndrome. Hypertension 55: 813-818, 2010
23. de Paula RB, da Silva AA, Hall JE: Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension 43: 41-47, 2004
24. de Souza F, Muxfeldt E, Fiszman R, Salles G: Efficacy of spironolactone therapy in patients with true resistant hypertension. Hypertension 55: 147-152, 2010
25. Nishizaka MK, Zaman MA, Calhoun DA: Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens 16: 925-930, 2003
26. Farjah M, Roxas BP, Geenen DL, Danziger RS: Dietary salt regulates renal SGK1 abundance: Relevance to salt sensitivity in the Dahl rat. Hypertension 41: 874-878, 2003
27. Aoi W, Niisato N, Sawabe Y, Miyazaki H, Marunaka Y: Aldosterone-induced abnormal regulation of ENaC and SGK1 in Dahl saltsensitive rat. Biochem Biophys Res Commun 341: 376-381, 2006
28. Massaad C, Houard N, LombèsM, Barouki R: Modulation of human mineralocorticoid receptor function by protein kinase A. Mol Endocrinol 13: 57-65, 1999
29. Mihailidou AS, Loan Le TY, Mardini M, Funder JW: Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 54: 1306-1312, 2009
30. Funder JW: Minireview: Aldosterone and mineralocorticoid receptors: Past, present, and future. Endocrinology 151: 5098-5102, 2010
31. Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, Miyoshi J, Takai Y, Fujita T: Modification of mineralocorticoid receptor function by Rac1 GTPase: Implication in proteinuric kidney disease. Nat Med 14: 1370-1376, 2008
32. Jaffe IZ, Mendelsohn ME: Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ Res 96: 643-650, 2005
33. McCurley A, Pires PW, Bender SB, Aronovitz M, Zhao MJ, Metzger D, Chambon P, Hill MA, Dorrance AM, Mendelsohn ME, Jaffe IZ: Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat Med 18: 1429-1433, 2012
34. Luther JM, Luo P, Wang Z, Cohen SE, Kim HS, Fogo AB, Brown NJ: Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. Kidney Int 82: 643-651, 2012
35. Kawarazaki W, Nagase M, Yoshida S, Takeuchi M, Ishizawa K, Ayuzawa N, Ueda K, Fujita T: Angiotensin II-and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation. J Am Soc Nephrol 23: 997-1007, 2012
36. Kobori H, Nangaku M, Navar LG, Nishiyama A: The intrarenal renin-angiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251-287, 2007
37. Rodríguez-Iturbe B, Pons H, Quiroz Y, Lanaspa MA, Johnson RJ: Autoimmunity in the pathogenesis of hypertension. Nat Rev Nephrol 10: 56-62, 2014
38. Freeley M, O'Dowd F, Paul T, Kashanin D, Davies A, Kelleher D, Long A: L-plastin regulates polarization and migration in chemokine-stimulated human T lymphocytes. J Immunol 188: 6357-6370, 2012
39. Ghosh MC, Baatar D, Collins G, Carter A, Indig F, Biragyn A, Taub DD: Dexamethasone augments CXCR4-mediated signaling in resting human T cells via the activation of the Src kinase Lck. Blood 113: 575-584, 2009
40. Kasal DA, Barhoumi T, Li MW, Yamamoto N, Zdanovich E, Rehman A, Neves MF, Laurant P, Paradis P, Schiffrin EL: T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension 59: 324-330, 2012
41. Rautureau Y, Paradis P, Schiffrin EL: Crosstalk between aldosterone and angiotensin signaling in vascular smooth muscle cells. Steroids 76: 834-839, 2011
42. Rickard AJ, Morgan J, Tesch G, Funder JW, Fuller PJ, Young MJ: Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure. Hypertension 54: 537-543, 2009
43. Usher MG, Duan SZ, Ivaschenko CY, Frieler RA, Berger S, Schütz G, Lumeng CN, Mortensen RM: Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest 120: 3350-3364, 2010
44. Jacob F, Clark LA, Guzman PA, Osborn JW: Role of renal nerves in development of hypertension in DOCA-salt model in rats: A telemetric approach. AmJ Physiol Heart Circ Physiol 289: H1519-H1529, 2005
45. Foss JD, Fink GD, Osborn JW: Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation. Hypertension 61: 806-811, 2013
46. Campese VM, Romoff MS, Levitan D, Saglikes Y, Friedler RM, Massry SG: Abnormal relationship between sodium intake and sympathetic nervous system activity in saltsensitive patients with essential hypertension. Kidney Int 21: 371-378, 1982
47. Gill JR Jr., Güllner GR Jr., Lake CR, Lakatua DJ, Lan G: Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension. Hypertension 11: 312-319, 1988
48. Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G, Lambert E: Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 48: 787-796, 2006
49. Lohmeier TE, Iliescu R, Liu B, Henegar JR, Maric-Bilkan C, Irwin ED: Systemic and renalspecific sympathoinhibition in obesity hypertension. Hypertension 59: 331-338, 2012
50. Nagae A, Fujita M, Kawarazaki H, Matsui H, Ando K, Fujita T: Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension. Circulation 119: 978-986, 2009
51. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M: Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study. Lancet 373: 1275-1281, 2009
52. EslerMD, KrumH, Sobotka PA, SchlaichMP, Schmieder RE, Böhm M; Symplicity HTN-2 Investigators: Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial. Lancet 376: 1903-1909, 2010
53. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell'Italia LJ, Calhoun DA: Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: Results from a randomized trial. Hypertension 54: 475-481, 2009
54. Ho HH, Foo D, Ong PJ: Successful preoperative treatment of a patient with resistant hypertension who had percutaneous renal denervation therapy before bariatric surgery. J Clin Hypertens (Greenwich) 14: 569-570, 2012
55. Papademetriou V, Tsioufis C, Stefanadis C: Impressive blood pressure and heart rate response after percutaneous renal denervation in a woman with morbid obesity and severe drug-resistant hypertension. J Clin Hypertens (Greenwich) 15: 852-855, 2013
56. DiBona GF: Physiology in perspective: The Wisdom of the Body. Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol 289: R633-R641, 2005
57. Sato Y, Ando K, Ogata E, Fujita T: High potassium intake attenuates antinatriuretic response to air stress in DOCA-salt rats. Am J Physiol 260: R941-R945, 1991
58. Yang CL, Angell J, Mitchell R, Ellison DH: WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 111: 1039-1045, 2003
59. Zhou B, Zhuang J, Gu D, Wang H, Cebotaru L, Guggino WB, Cai H: WNK4 enhances the degradation of NCC through a sortilinmediated lysosomal pathway. J Am Soc Nephrol 21: 82-92, 2010
60. Zhou B, Wang D, Feng X, Zhang Y, Wang Y, Zhuang J, Zhang X, Chen G, Delpire E, Gu D, Cai H: WNK4 inhibits NCC protein expression through MAPK ERK1/2 signaling pathway. Am J Physiol Renal Physiol 302: F533-F539, 2012
61. Lalioti MD, Zhang J, Volkman HM, Kahle KT, Hoffmann KE, Toka HR, Nelson-Williams C, Ellison DH, Flavell R, Booth CJ, Lu Y, Geller DS, Lifton RP: Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 38: 1124-1132, 2006
62. O'Reilly M, Marshall E, Macgillivray T, Mittal M, Xue W, Kenyon CJ, Brown RW: Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo. J Am Soc Nephrol 17: 2402-2413, 2006
63. Lai L, Feng X, Liu D, Chen J, Zhang Y, Niu B, Gu Y, Cai H: Dietary salt modulates the sodiumchloride cotransporter expression likely through an aldosterone-mediated WNK4-ERK1/2 signaling pathway. Pflugers Arch 463: 477-485, 2012
64. Chiga M, Rai T, Yang SS, Ohta A, Takizawa T, Sasaki S, Uchida S: Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone. Kidney Int 74: 1403-1409, 2008
65. Castañeda-Bueno M, Cervantes-Pérez LG, Vázquez N, Uribe N, Kantesaria S, Morla L, Bobadilla NA, Doucet A, Alessi DR, Gamba G: Activation of the renal Na+:Cl-cotransporter by angiotensin II is aWNK4-dependent process. Proc Natl Acad Sci U S A 109: 7929-7934, 2012
66. Greven J, Heidenreich O: A micropuncture study of the effect of isoprenaline on renal tubular fluid and electrolyte transport in the rat. Naunyn Schmiedebergs Arch Pharmacol 287: 117-128, 1975
67. Meier KE, Snavely MD, Brown SL, Brown JH, Insel PA: a 1-and b 2-adrenergic receptor expression in the Madin-Darby canine kidney epithelial cell line. J Cell Biol 97: 405-415, 1983
68. Snyder EM, Turner ST, Joyner MJ, Eisenach JH, JohnsonBD: The Arg16Gly polymorphism of the b2-adrenergic receptor and the natriuretic response to rapid saline infusion in humans. J Physiol 574: 947-954, 2006
69. Pojoga L, Kolatkar NS, Williams JS, Perlstein TS, Jeunemaitre X, Brown NJ, Hopkins PN, Raby BA, Williams GH: b-2 adrenergic receptor diplotype defines a subset of saltsensitive hypertension. Hypertension 48: 892-900, 2006
70. Ko B,Mistry AC, Hanson LN,Mallick R, Wynne BM, Thai TL, Bailey JL, Klein JD, Hoover RS: Aldosterone acutely stimulates NCC activity via a SPAK-mediated pathway. Am J Physiol Renal Physiol 305: F645-F652, 2013
71. Lee H, Rezai-Zadeh N, Seto E: Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A. Mol Cell Biol 24: 765-773, 2004
72. Li C, Li Y, Li Y, Liu H, Sun Z, Lu J, Zhao Y: Glucocorticoid repression of human withno-lysine (K) kinase-4 gene expression is mediated by the negative response elements in the promoter. JMol Endocrinol 40: 3-12, 2008
73. Bostanjoglo M, Reeves WB, Reilly RF, Velázquez H, Robertson N, Litwack G, Morsing P,Dørup J, Bachmann S, EllisonDH: 11b-hydroxysteroid dehydrogenase, mineralocorticoid receptor, and thiazide-sensitive Na-Cl cotransporter expression by distal tubules. J Am Soc Nephrol 9: 1347-1358, 1998
74. Câmpean V, Kricke J, Ellison D, Luft FC, Bachmann S: Localization of thiazide-sensitive Na(+)-Cl(-) cotransport and associated gene products in mouse DCT. Am J Physiol Renal Physiol 281: F1028-F1035, 2001
75. Ellison DH, Brooks VL: Renal nerves, WNK4, glucocorticoids, and salt transport. Cell Metab 13: 619-620, 2011
76. Rozansky DJ, Cornwall T, Subramanya AR, Rogers S, Yang YF, David LL, Zhu X, Yang CL, Ellison DH: Aldosterone mediates activation of the thiazide-sensitive Na-Cl cotransporter through an SGK1 and WNK4 signaling pathway. J Clin Invest 119: 2601-2612, 2009
77. Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, Martin M: The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 321: 580-585, 1989
78. Komers R, Rogers S, Oyama TT, Xu B, Yang C-L, McCormick J, Ellison DH: Enhanced phosphorylation of Na(+)-Cl-co-transporter in experimental metabolic syndrome: Role of insulin. Clin Sci (Lond) 123: 635-647, 2012
79. Nishida H, Sohara E, Nomura N, Chiga M, Alessi DR, Rai T, Sasaki S, Uchida S: Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAKNCC phosphorylation cascade in hyperinsulinemic db/db mice. Hypertension 60: 981-990, 2012
80. Hoorn EJ, Walsh SB, McCormick JA, Fürstenberg A, Yang CL, Roeschel T, Paliege A, Howie AJ, Conley J, Bachmann S, Unwin RJ, Ellison DH: The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. Nat Med 17: 1304-1309, 2011
81. McCormick JA, Nelson JH, Yang CL, Curry JN, Ellison DH: Overexpression of the sodium chloride cotransporter is not sufficient to cause familial hyperkalemic hypertension. Hypertension 58: 888-894, 2011
82. Subramanya AR, Yang CL, Zhu X, Ellison DH: Dominant-negative regulation ofWNK1 by its kidney-specific kinase-defective isoform.Am J Physiol Renal Physiol 290: F619-F624, 2006
83. Hadchouel J, Soukaseum C, Büsst C, Zhou XO, Baudrie V, Zürrer T, Cambillau M, Elghozi JL, Lifton RP, Loffing J, Jeunemaitre X: Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension. Proc Natl Acad Sci U S A 107: 18109-18114, 2010
84. Ponce-Coria J, San-Cristobal P, Kahle KT, VazquezN, Pacheco-Alvarez D, de Los Heros P, Juárez P, Muñoz E, Michel G, Bobadilla NA, Gimenez I, Lifton RP, Hebert SC, Gamba G: Regulation ofNKCC2by a chloride-sensing mechanism involving the WNK3 and SPAK kinases. Proc Natl Acad Sci U S A 105: 8458-8463, 2008
85. McCormick JA, Mutig K, Nelson JH, Saritas T, Hoorn EJ, Yang CL, Rogers S, Curry J, Delpire E, Bachmann S, Ellison DH: A SPAK isoform switch modulates renal salt transport and blood pressure. Cell Metab 14: 352-364, 2011
86. Kahle KT, Gimenez I, Hassan H, Wilson FH, Wong RD, Forbush B, Aronson PS, Lifton RP: WNK4 regulates apical and basolateral Cl-flux in extrarenal epithelia. Proc Natl Acad Sci U S A 101: 2064-2069, 2004
87. Park HW, Kim JY, Choi S-K, Lee YH, Zeng W, KimKH,MuallemS, LeeMG: Serine-threonine kinase with-no-lysine 4 (WNK4) controls blood pressure via transient receptor potential canonical 3 (TRPC3) in the vasculature. Proc Natl Acad Sci U S A 108: 10750-10755, 2011